| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | ATP8B3 SEC61A2 ABCC1 MFSD2A KCNT2 SLC2A6 SPNS2 SLC22A4 SLC22A5 SLC6A15 CACNA1H CACNA1G SLC38A11 NMUR2 SEC61A1 ATP13A2 SLC1A2 TAP1 SLC23A2 SLC39A13 ABCB4 TMEM63A | 6.64e-09 | 1289 | 82 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SEC61A2 ABCC1 MFSD2A KCNT2 SLC2A6 SPNS2 SLC22A4 SLC22A5 SLC6A15 CACNA1H CACNA1G SLC38A11 NMUR2 SEC61A1 ATP13A2 SLC1A2 TAP1 SLC23A2 SLC39A13 ABCB4 TMEM63A | 7.67e-09 | 1180 | 82 | 21 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC1 MFSD2A SLC22A4 SLC22A5 SLC6A15 ATP13A2 SLC1A2 TAP1 SLC23A2 ABCB4 | 2.53e-05 | 477 | 82 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | symporter activity | 3.56e-05 | 150 | 82 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.86e-05 | 49 | 82 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 4.98e-05 | 3 | 82 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC1 MFSD2A KCNT2 SLC6A15 CACNA1H CACNA1G NMUR2 SEC61A1 SLC1A2 SLC23A2 SLC39A13 TMEM63A | 5.93e-05 | 758 | 82 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 7.24e-05 | 20 | 82 | 3 | GO:0046624 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 7.39e-05 | 171 | 82 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | MFSD2A KCNT2 SLC6A15 CACNA1H CACNA1G SEC61A1 ATP13A2 SLC1A2 SLC23A2 SLC39A13 TMEM63A | 8.30e-05 | 664 | 82 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | MFSD2A KCNT2 SLC6A15 CACNA1H CACNA1G NMUR2 SEC61A1 ATP13A2 SLC1A2 SLC23A2 SLC39A13 TMEM63A | 9.12e-05 | 793 | 82 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | amino-acid betaine transmembrane transporter activity | 9.94e-05 | 4 | 82 | 2 | GO:0015199 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | MFSD2A KCNT2 SLC6A15 CACNA1H CACNA1G SEC61A1 SLC1A2 SLC23A2 SLC39A13 | 1.21e-04 | 465 | 82 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 2.03e-04 | 293 | 82 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.03e-04 | 28 | 82 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.10e-04 | 207 | 82 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.15e-04 | 208 | 82 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | MFSD2A KCNT2 SLC6A15 CACNA1H CACNA1G SEC61A1 SLC1A2 SLC23A2 SLC39A13 TMEM63A | 2.43e-04 | 627 | 82 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | carnitine transmembrane transporter activity | 2.47e-04 | 6 | 82 | 2 | GO:0015226 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 3.33e-04 | 33 | 82 | 3 | GO:0072349 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor activity | 3.45e-04 | 7 | 82 | 2 | GO:0005021 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.46e-04 | 81 | 82 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 3.97e-04 | 35 | 82 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 4.32e-04 | 36 | 82 | 3 | GO:0090482 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 9.22e-04 | 105 | 82 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.06e-03 | 109 | 82 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.07e-03 | 12 | 82 | 2 | GO:0017154 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GIPR DDR1 OR51S1 CD300LD HTR2C OR6S1 SPN NMUR2 OR2Z1 TNFRSF1A SSTR1 NRP2 NRP1 TMEM63A | 1.14e-03 | 1353 | 82 | 14 | GO:0004888 |
| GeneOntologyMolecularFunction | signal sequence binding | 1.21e-03 | 51 | 82 | 3 | GO:0005048 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.21e-03 | 51 | 82 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.28e-03 | 196 | 82 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.37e-03 | 296 | 82 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.47e-03 | 119 | 82 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.47e-03 | 14 | 82 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | quaternary ammonium group transmembrane transporter activity | 1.69e-03 | 15 | 82 | 2 | GO:0015651 | |
| GeneOntologyMolecularFunction | floppase activity | 1.93e-03 | 16 | 82 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | peptide binding | 1.98e-03 | 318 | 82 | 6 | GO:0042277 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.43e-03 | 65 | 82 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | long-chain fatty acid transmembrane transporter activity | 2.44e-03 | 18 | 82 | 2 | GO:0005324 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 3.33e-03 | 21 | 82 | 2 | GO:0005326 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 3.51e-03 | 74 | 82 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | fatty acid transmembrane transporter activity | 3.99e-03 | 23 | 82 | 2 | GO:0015245 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 3.99e-03 | 23 | 82 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | cyclase activity | 4.34e-03 | 24 | 82 | 2 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 4.70e-03 | 25 | 82 | 2 | GO:0016849 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 4.84e-03 | 83 | 82 | 3 | GO:0015101 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 5.08e-03 | 26 | 82 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 5.18e-03 | 85 | 82 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 5.47e-03 | 27 | 82 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | protein transmembrane transporter activity | 5.88e-03 | 28 | 82 | 2 | GO:0008320 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 6.22e-03 | 178 | 82 | 4 | GO:0015399 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 6.29e-03 | 29 | 82 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 6.29e-03 | 29 | 82 | 2 | GO:0051119 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 7.17e-03 | 31 | 82 | 2 | GO:0022839 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 7.99e-03 | 301 | 82 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 8.58e-03 | 34 | 82 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 8.58e-03 | 34 | 82 | 2 | GO:0022884 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 9.58e-03 | 441 | 82 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 1.01e-02 | 37 | 82 | 2 | GO:0042923 | |
| GeneOntologyBiologicalProcess | ganglion morphogenesis | 1.60e-05 | 2 | 83 | 2 | GO:0061552 | |
| GeneOntologyBiologicalProcess | dorsal root ganglion morphogenesis | 1.60e-05 | 2 | 83 | 2 | GO:1904835 | |
| GeneOntologyBiologicalProcess | vestibulocochlear nerve structural organization | 1.60e-05 | 2 | 83 | 2 | GO:0021649 | |
| GeneOntologyBiologicalProcess | organic cation transport | 2.63e-05 | 145 | 83 | 6 | GO:0015695 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ABCC1 HTR2C KCNT2 SLC22A4 SLC22A5 SLC6A15 CACNA1H CACNA1G SLC38A11 NMUR2 SEC61A1 ATP13A2 SLC1A2 SLC23A2 CRH SLC39A13 TMEM63A | 2.76e-05 | 1374 | 83 | 17 | GO:0006811 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | ABCC1 MFSD2A HTR2C SLC6A15 SLC38A11 NMUR2 SLC1A2 SLC23A2 ABCB4 | 3.98e-05 | 410 | 83 | 9 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic anion transport | ABCC1 MFSD2A HTR2C SLC2A6 SLC6A15 SLC38A11 NMUR2 SLC1A2 SLC23A2 ABCB4 | 4.10e-05 | 515 | 83 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | organic acid transport | ABCC1 MFSD2A HTR2C SLC6A15 SLC38A11 NMUR2 SLC1A2 SLC23A2 ABCB4 | 4.13e-05 | 412 | 83 | 9 | GO:0015849 |
| GeneOntologyBiologicalProcess | facioacoustic ganglion development | 4.79e-05 | 3 | 83 | 2 | GO:1903375 | |
| GeneOntologyBiologicalProcess | sensory neuron axon guidance | 4.79e-05 | 3 | 83 | 2 | GO:0097374 | |
| GeneOntologyBiologicalProcess | positive regulation of digestive system process | 5.81e-05 | 19 | 83 | 3 | GO:0060456 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 7.11e-05 | 55 | 83 | 4 | GO:0045332 | |
| GeneOntologyBiologicalProcess | ventral trunk neural crest cell migration | 9.55e-05 | 4 | 83 | 2 | GO:0036486 | |
| GeneOntologyBiologicalProcess | sympathetic neuron projection guidance | 9.55e-05 | 4 | 83 | 2 | GO:0097491 | |
| GeneOntologyBiologicalProcess | lipid translocation | 1.00e-04 | 60 | 83 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.21e-04 | 275 | 83 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 1.29e-04 | 64 | 83 | 4 | GO:0042908 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 1.37e-04 | 65 | 83 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | trigeminal ganglion development | 1.59e-04 | 5 | 83 | 2 | GO:0061551 | |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 1.59e-04 | 5 | 83 | 2 | GO:0099039 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | HTR2C KCNT2 SLC22A4 SLC22A5 SLC6A15 CACNA1H CACNA1G SLC38A11 SEC61A1 ATP13A2 SLC23A2 CRH SLC39A13 TMEM63A | 1.97e-04 | 1157 | 83 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | trunk neural crest cell migration | 2.37e-04 | 6 | 83 | 2 | GO:0036484 | |
| GeneOntologyBiologicalProcess | sympathetic neuron projection extension | 2.37e-04 | 6 | 83 | 2 | GO:0097490 | |
| GeneOntologyBiologicalProcess | trunk segmentation | 2.37e-04 | 6 | 83 | 2 | GO:0035290 | |
| GeneOntologyBiologicalProcess | cranial ganglion development | 2.37e-04 | 6 | 83 | 2 | GO:0061550 | |
| GeneOntologyBiologicalProcess | trigeminal nerve morphogenesis | 2.37e-04 | 6 | 83 | 2 | GO:0021636 | |
| GeneOntologyBiologicalProcess | trigeminal nerve structural organization | 2.37e-04 | 6 | 83 | 2 | GO:0021637 | |
| GeneOntologyBiologicalProcess | modified amino acid metabolic process | 2.49e-04 | 218 | 83 | 6 | GO:0006575 | |
| GeneOntologyBiologicalProcess | hypothalamus development | 2.60e-04 | 31 | 83 | 3 | GO:0021854 | |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 3.25e-04 | 229 | 83 | 6 | GO:0006643 | |
| GeneOntologyBiologicalProcess | gonadotrophin-releasing hormone neuronal migration to the hypothalamus | 3.32e-04 | 7 | 83 | 2 | GO:0021828 | |
| GeneOntologyBiologicalProcess | hypothalamic tangential migration using cell-axon interactions | 3.32e-04 | 7 | 83 | 2 | GO:0021856 | |
| GeneOntologyBiologicalProcess | branchiomotor neuron axon guidance | 3.32e-04 | 7 | 83 | 2 | GO:0021785 | |
| GeneOntologyBiologicalProcess | neural crest cell migration involved in autonomic nervous system development | 3.32e-04 | 7 | 83 | 2 | GO:1901166 | |
| GeneOntologyBiologicalProcess | vestibulocochlear nerve morphogenesis | 3.32e-04 | 7 | 83 | 2 | GO:0021648 | |
| GeneOntologyBiologicalProcess | dorsal root ganglion development | 3.32e-04 | 7 | 83 | 2 | GO:1990791 | |
| GeneOntologyBiologicalProcess | carnitine transmembrane transport | 3.32e-04 | 7 | 83 | 2 | GO:1902603 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 4.21e-04 | 87 | 83 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 4.40e-04 | 88 | 83 | 4 | GO:0010232 | |
| GeneOntologyBiologicalProcess | SRP-dependent cotranslational protein targeting to membrane, translocation | 4.41e-04 | 8 | 83 | 2 | GO:0006616 | |
| GeneOntologyBiologicalProcess | post-translational protein targeting to membrane, translocation | 4.41e-04 | 8 | 83 | 2 | GO:0031204 | |
| GeneOntologyBiologicalProcess | intestinal epithelial structure maintenance | 4.41e-04 | 8 | 83 | 2 | GO:0060729 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ABCC1 HTR2C KCNT2 SLC6A15 CACNA1H CACNA1G NMUR2 SEC61A1 ATP13A2 SLC1A2 SLC23A2 SLC39A13 TMEM63A | 4.88e-04 | 1115 | 83 | 13 | GO:0034220 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 5.12e-04 | 163 | 83 | 5 | GO:1905039 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid metabolic process | 5.58e-04 | 40 | 83 | 3 | GO:1903725 | |
| GeneOntologyBiologicalProcess | hypothalamus cell migration | 5.65e-04 | 9 | 83 | 2 | GO:0021855 | |
| GeneOntologyBiologicalProcess | sympathetic ganglion development | 5.65e-04 | 9 | 83 | 2 | GO:0061549 | |
| GeneOntologyBiologicalProcess | hypothalamus gonadotrophin-releasing hormone neuron differentiation | 5.65e-04 | 9 | 83 | 2 | GO:0021886 | |
| GeneOntologyBiologicalProcess | hypothalamus gonadotrophin-releasing hormone neuron development | 5.65e-04 | 9 | 83 | 2 | GO:0021888 | |
| GeneOntologyBiologicalProcess | carnitine transport | 5.65e-04 | 9 | 83 | 2 | GO:0015879 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 5.72e-04 | 167 | 83 | 5 | GO:1903825 | |
| GeneOntologyBiologicalProcess | metal ion transport | HTR2C KCNT2 SLC22A4 SLC22A5 SLC6A15 CACNA1H CACNA1G SLC38A11 SEC61A1 SLC23A2 CRH SLC39A13 | 6.37e-04 | 1000 | 83 | 12 | GO:0030001 |
| GeneOntologyBiologicalProcess | cellular response to cocaine | 7.05e-04 | 10 | 83 | 2 | GO:0071314 | |
| GeneOntologyBiologicalProcess | facial nerve structural organization | 7.05e-04 | 10 | 83 | 2 | GO:0021612 | |
| GeneOntologyBiologicalProcess | circulatory system process | ABCC1 MFSD2A HTR2C SLC22A5 CPA3 CACNA1H CACNA1G SLC1A2 SLC23A2 CRH | 7.08e-04 | 733 | 83 | 10 | GO:0003013 |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 7.25e-04 | 176 | 83 | 5 | GO:0006665 | |
| GeneOntologyBiologicalProcess | modified amino acid transport | 7.39e-04 | 44 | 83 | 3 | GO:0072337 | |
| GeneOntologyBiologicalProcess | vestibulocochlear nerve development | 8.59e-04 | 11 | 83 | 2 | GO:0021562 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 8.87e-04 | 106 | 83 | 4 | GO:0015914 | |
| GeneOntologyBiologicalProcess | facial nerve morphogenesis | 1.03e-03 | 12 | 83 | 2 | GO:0021610 | |
| GeneOntologyBiologicalProcess | facial nerve development | 1.03e-03 | 12 | 83 | 2 | GO:0021561 | |
| GeneOntologyBiologicalProcess | secretion | GIPR DDR1 CAD HTR2C DIO2 CACNA1H CACNA1G NMUR2 TNFRSF1A ATP13A2 CRH ABCB4 TMEM63A | 1.13e-03 | 1221 | 83 | 13 | GO:0046903 |
| GeneOntologyBiologicalProcess | regulation of digestive system process | 1.14e-03 | 51 | 83 | 3 | GO:0044058 | |
| GeneOntologyBiologicalProcess | amino acid transport | 1.15e-03 | 195 | 83 | 5 | GO:0006865 | |
| GeneOntologyBiologicalProcess | cranial nerve structural organization | 1.21e-03 | 13 | 83 | 2 | GO:0021604 | |
| GeneOntologyBiologicalProcess | trigeminal nerve development | 1.21e-03 | 13 | 83 | 2 | GO:0021559 | |
| GeneOntologyBiologicalProcess | carnitine metabolic process | 1.21e-03 | 13 | 83 | 2 | GO:0009437 | |
| GeneOntologyBiologicalProcess | acetate ester transport | 1.21e-03 | 13 | 83 | 2 | GO:1901374 | |
| GeneOntologyBiologicalProcess | sphingolipid biosynthetic process | 1.28e-03 | 117 | 83 | 4 | GO:0030148 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.41e-03 | 120 | 83 | 4 | GO:0003333 | |
| GeneOntologyBiologicalProcess | hypothalamus cell differentiation | 1.41e-03 | 14 | 83 | 2 | GO:0021979 | |
| GeneOntologyBiologicalProcess | amino-acid betaine transport | 1.41e-03 | 14 | 83 | 2 | GO:0015838 | |
| GeneOntologyBiologicalProcess | vitamin transport | 1.49e-03 | 56 | 83 | 3 | GO:0051180 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 1.49e-03 | 207 | 83 | 5 | GO:1990138 | |
| GeneOntologyBiologicalProcess | amide transport | 1.52e-03 | 420 | 83 | 7 | GO:0042886 | |
| GeneOntologyCellularComponent | Sec61 translocon complex | 1.66e-04 | 5 | 86 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | translocon complex | 2.48e-04 | 6 | 86 | 2 | GO:0071256 | |
| MousePheno | enophthalmos | 1.23e-05 | 10 | 67 | 3 | MP:0006198 | |
| Domain | LRRC37AB_C | 3.50e-07 | 4 | 84 | 3 | PF14914 | |
| Domain | LRRC37_N | 3.50e-07 | 4 | 84 | 3 | IPR032754 | |
| Domain | LRRC37AB_C | 3.50e-07 | 4 | 84 | 3 | IPR029423 | |
| Domain | LRRC37 | 3.50e-07 | 4 | 84 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 3.50e-07 | 4 | 84 | 3 | IPR015753 | |
| Domain | Neuropilin | 2.00e-05 | 2 | 84 | 2 | IPR014648 | |
| Domain | Plug_translocon | 2.00e-05 | 2 | 84 | 2 | PF10559 | |
| Domain | DUF3481 | 2.00e-05 | 2 | 84 | 2 | PF11980 | |
| Domain | SecY_su_dom | 2.00e-05 | 2 | 84 | 2 | IPR023201 | |
| Domain | Neuropilin_C | 2.00e-05 | 2 | 84 | 2 | IPR022579 | |
| Domain | SecY | 2.00e-05 | 2 | 84 | 2 | PF00344 | |
| Domain | SECY_1 | 2.00e-05 | 2 | 84 | 2 | PS00755 | |
| Domain | SECY_2 | 2.00e-05 | 2 | 84 | 2 | PS00756 | |
| Domain | - | 2.00e-05 | 2 | 84 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 2.00e-05 | 2 | 84 | 2 | IPR019561 | |
| Domain | SecY_CS | 2.00e-05 | 2 | 84 | 2 | IPR030659 | |
| Domain | SecY/SEC61-alpha | 2.00e-05 | 2 | 84 | 2 | IPR002208 | |
| Domain | MAM | 5.70e-05 | 17 | 84 | 3 | SM00137 | |
| Domain | VDCC_T_a1 | 5.98e-05 | 3 | 84 | 2 | IPR005445 | |
| Domain | MAM | 6.82e-05 | 18 | 84 | 3 | PF00629 | |
| Domain | MAM_dom | 6.82e-05 | 18 | 84 | 3 | IPR000998 | |
| Domain | MAM_2 | 6.82e-05 | 18 | 84 | 3 | PS50060 | |
| Domain | FA58C | 1.10e-04 | 21 | 84 | 3 | SM00231 | |
| Domain | FA58C_3 | 1.10e-04 | 21 | 84 | 3 | PS50022 | |
| Domain | FA58C_1 | 1.10e-04 | 21 | 84 | 3 | PS01285 | |
| Domain | FA58C_2 | 1.10e-04 | 21 | 84 | 3 | PS01286 | |
| Domain | MFS | 1.26e-04 | 108 | 84 | 5 | PS50850 | |
| Domain | F5_F8_type_C | 1.66e-04 | 24 | 84 | 3 | PF00754 | |
| Domain | FA58C | 1.66e-04 | 24 | 84 | 3 | IPR000421 | |
| Domain | SUGAR_TRANSPORT_1 | 1.66e-04 | 24 | 84 | 3 | PS00216 | |
| Domain | ABC_membrane | 1.66e-04 | 24 | 84 | 3 | PF00664 | |
| Domain | ABC_TM1F | 2.65e-04 | 28 | 84 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 2.65e-04 | 28 | 84 | 3 | IPR011527 | |
| Domain | - | 3.27e-04 | 73 | 84 | 4 | 2.60.120.260 | |
| Domain | MFS_dom | 3.46e-04 | 134 | 84 | 5 | IPR020846 | |
| Domain | Sugar_transporter_CS | 3.96e-04 | 32 | 84 | 3 | IPR005829 | |
| Domain | Glyco_hydro_31 | 4.14e-04 | 7 | 84 | 2 | IPR000322 | |
| Domain | Glyco_hydro_31 | 4.14e-04 | 7 | 84 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 4.14e-04 | 7 | 84 | 2 | PS00129 | |
| Domain | MFS_sugar_transport-like | 5.63e-04 | 36 | 84 | 3 | IPR005828 | |
| Domain | Sugar_tr | 5.63e-04 | 36 | 84 | 3 | PF00083 | |
| Domain | Orgcat_transp/SVOP | 7.05e-04 | 9 | 84 | 2 | IPR004749 | |
| Domain | Galactose-bd-like | 8.54e-04 | 94 | 84 | 4 | IPR008979 | |
| Domain | VDCCAlpha1 | 8.79e-04 | 10 | 84 | 2 | IPR002077 | |
| Domain | ABC_transporter_CS | 8.88e-04 | 42 | 84 | 3 | IPR017871 | |
| Domain | ABC_tran | 1.31e-03 | 48 | 84 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.31e-03 | 48 | 84 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.39e-03 | 49 | 84 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 1.48e-03 | 50 | 84 | 3 | IPR003439 | |
| Domain | MAM_1 | 2.30e-03 | 16 | 84 | 2 | PS00740 | |
| Domain | AAA+_ATPase | 4.06e-03 | 144 | 84 | 4 | IPR003593 | |
| Domain | AAA | 4.06e-03 | 144 | 84 | 4 | SM00382 | |
| Domain | ARM-type_fold | 4.24e-03 | 339 | 84 | 6 | IPR016024 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 22419166 | ||
| Pubmed | 8.10e-07 | 8 | 86 | 3 | 36049228 | ||
| Pubmed | 1.21e-06 | 9 | 86 | 3 | 18338763 | ||
| Pubmed | 1.73e-06 | 10 | 86 | 3 | 19261698 | ||
| Pubmed | 1.73e-06 | 10 | 86 | 3 | 23064749 | ||
| Pubmed | 1.73e-06 | 10 | 86 | 3 | 24778262 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21695374 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 16469794 | ||
| Pubmed | Aberrant expression of neuropilin-1 and -2 in human pancreatic cancer cells. | 6.04e-06 | 2 | 86 | 2 | 14760080 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 14988077 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21910182 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 18274826 | ||
| Pubmed | Advanced glycation end-products suppress neuropilin-1 expression in podocytes. | 6.04e-06 | 2 | 86 | 2 | 19037249 | |
| Pubmed | Distinct submembrane localisation compartmentalises cardiac NPR1 and NPR2 signalling to cGMP. | 6.04e-06 | 2 | 86 | 2 | 29934640 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21622683 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 30717262 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 19814996 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 20685979 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 11112349 | ||
| Pubmed | Segregation Analysis of Rare NRP1 and NRP2 Variants in Families with Lymphedema. | 6.04e-06 | 2 | 86 | 2 | 33212964 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21606177 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 20020740 | ||
| Pubmed | Human neuropilin-1 and neuropilin-2 map to 10p12 and 2q34, respectively. | 6.04e-06 | 2 | 86 | 2 | 10329017 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 15613413 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 23436820 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 30862875 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 31042060 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 16333318 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21793125 | ||
| Pubmed | SLC22A4 and SLC22A5 gene polymorphisms and Crohn's disease in the Chinese Han population. | 6.04e-06 | 2 | 86 | 2 | 19659785 | |
| Pubmed | Characterization of organic cation/carnitine transporter family in human sperm. | 6.04e-06 | 2 | 86 | 2 | 12788076 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21706137 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22325173 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 35710838 | ||
| Pubmed | Molecular and functional characterization of organic cation/carnitine transporter family in mice. | 6.04e-06 | 2 | 86 | 2 | 11010964 | |
| Pubmed | Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2. | 6.04e-06 | 2 | 86 | 2 | 18708346 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 18480044 | ||
| Pubmed | Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer. | 6.04e-06 | 2 | 86 | 2 | 23551578 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 11939589 | ||
| Pubmed | Expression patterns of the organic cation/carnitine transporter family in adult murine brain. | 6.04e-06 | 2 | 86 | 2 | 17576045 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 19141711 | ||
| Pubmed | Endothelial VEGFR Coreceptors Neuropilin-1 and Neuropilin-2 Are Essential for Tumor Angiogenesis. | 6.04e-06 | 2 | 86 | 2 | 36970722 | |
| Pubmed | Contribution of the IBD5 locus to Crohn's disease in the Swedish population. | 6.04e-06 | 2 | 86 | 2 | 17340776 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21653940 | ||
| Pubmed | The wiring of Grueneberg ganglion axons is dependent on neuropilin 1. | 6.04e-06 | 2 | 86 | 2 | 22745317 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 17387389 | ||
| Pubmed | MFSD2a, the Syncytin-2 receptor, is important for trophoblast fusion. | 6.04e-06 | 2 | 86 | 2 | 23177091 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 32964310 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 16835882 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22469755 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 19581171 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 16519742 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 17917967 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21079360 | ||
| Pubmed | Functional activity of L-carnitine transporters in human airway epithelial cells. | 6.04e-06 | 2 | 86 | 2 | 26607009 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 16773684 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22886848 | ||
| Pubmed | Organic cation/carnitine transporter family expression patterns in adult murine heart. | 6.04e-06 | 2 | 86 | 2 | 19233567 | |
| Pubmed | Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. | 6.04e-06 | 2 | 86 | 2 | 18065694 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 18641280 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 29082441 | ||
| Pubmed | Evidence for association of OCTN genes and IBD5 with ulcerative colitis. | 6.04e-06 | 2 | 86 | 2 | 16361305 | |
| Pubmed | Presence of the Transmembrane Protein Neuropilin in Cytokine-induced Killer Cells. | 6.04e-06 | 2 | 86 | 2 | 32988871 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22574369 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 16796743 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 30806307 | ||
| Pubmed | Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. | 6.04e-06 | 2 | 86 | 2 | 21438841 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 19736548 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 33461580 | ||
| Pubmed | β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A. | 6.04e-06 | 2 | 86 | 2 | 22808078 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 23127916 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 31591905 | ||
| Pubmed | 8.62e-06 | 52 | 86 | 4 | 26590417 | ||
| Pubmed | 1.17e-05 | 430 | 86 | 8 | 16303743 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 24327205 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 21393251 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 19741298 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 9778357 | ||
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 1.81e-05 | 3 | 86 | 2 | 23488970 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 24966091 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 15685536 | ||
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 1.81e-05 | 3 | 86 | 2 | 11230107 | |
| Pubmed | Functional variants of OCTN cation transporter genes are associated with Crohn disease. | 1.81e-05 | 3 | 86 | 2 | 15107849 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 19474288 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 33547341 | ||
| Pubmed | Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain. | 1.81e-05 | 3 | 86 | 2 | 20430450 | |
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 1.81e-05 | 3 | 86 | 2 | 28972185 | |
| Pubmed | Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. | 1.81e-05 | 3 | 86 | 2 | 16771961 | |
| Pubmed | Expression of placental growth factor, neuropilin-1, and neuropilin-2 in primary pterygium tissue. | 1.81e-05 | 3 | 86 | 2 | 37878035 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 19412005 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 20298787 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 25784603 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 11461151 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 22572848 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 22994200 | ||
| Pubmed | Secreted semaphorins modulate synaptic transmission in the adult hippocampus. | 1.81e-05 | 3 | 86 | 2 | 15814792 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 32070725 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 16441470 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 23145112 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 19214536 | ||
| GeneFamily | Solute carriers | SLC2A6 SLC22A4 SLC22A5 SLC6A15 SLC38A11 SLC1A2 SLC23A2 SLC39A13 | 2.40e-05 | 395 | 55 | 8 | 752 |
| GeneFamily | ATP binding cassette subfamily B | 4.91e-04 | 11 | 55 | 2 | 806 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.21e-03 | 394 | 55 | 6 | 471 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.82e-03 | 26 | 55 | 2 | 253 | |
| GeneFamily | EF-hand domain containing | 4.41e-03 | 219 | 55 | 4 | 863 | |
| Coexpression | MEL18_DN.V1_UP | 6.72e-06 | 141 | 85 | 6 | M2784 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-07 | 155 | 86 | 6 | cd2f3ad4f131588325a667b6724e530d821fbe30 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-07 | 155 | 86 | 6 | 9b26ade19488511c72b64335011d2dcd81e8f167 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-07 | 155 | 86 | 6 | 4246709e27703b94529369abbed5763e4002e79d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-06 | 180 | 86 | 6 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.04e-06 | 193 | 86 | 6 | 8603d1a38955ad2529d04e4704467c73ea5bfbda | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-06 | 194 | 86 | 6 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-06 | 194 | 86 | 6 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.16e-06 | 195 | 86 | 6 | 5f33ece997f074598b4201ff74f592ee07c86a06 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.47e-06 | 146 | 86 | 5 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Mast-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-05 | 159 | 86 | 5 | 81782e9e370558d61af5e0c760ac9759d69fb725 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-05 | 161 | 86 | 5 | 1f4614ae15bd2fc08e555cea4d0152c4a940d048 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 163 | 86 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 163 | 86 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-05 | 167 | 86 | 5 | 3b717d33aaf1ef0869cc4bca8432ba8008875cc5 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.87e-05 | 168 | 86 | 5 | 6c758eb120faf06ff72d157b495e399191c79ec9 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 168 | 86 | 5 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 171 | 86 | 5 | b51bbeacb172e8b5de519ada85543d7ae9914b3c | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 2.27e-05 | 175 | 86 | 5 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.33e-05 | 176 | 86 | 5 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 176 | 86 | 5 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-05 | 177 | 86 | 5 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_NE_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 178 | 86 | 5 | 32cc4155267baf1b536a61310044e6502d09531f | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 181 | 86 | 5 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 181 | 86 | 5 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.81e-05 | 183 | 86 | 5 | f9a3af96c0fb7d5c4d7df6db8b2c42e322418c08 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-05 | 184 | 86 | 5 | 1e6f86f9e379cd9f453f6b7185f681b44eb63e09 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-05 | 184 | 86 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.12e-05 | 187 | 86 | 5 | 98477ba04a42a8da80a72f41a182429f46283595 | |
| ToppCell | facs-Kidney-nan-24m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 189 | 86 | 5 | 9d02a824bba59ea0660439f0510d843568e9d8c3 | |
| ToppCell | facs-Kidney-nan-24m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 189 | 86 | 5 | 5f8d4b61296c71b32362432a9ce4c1c3aaeb278d | |
| ToppCell | facs-Kidney-nan-24m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 189 | 86 | 5 | 18f82764b32496e54d1a604a531b261651c5e110 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.36e-05 | 190 | 86 | 5 | 2375e604eacd38f61f3e661ba2f76d286fcceca7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.36e-05 | 190 | 86 | 5 | b1095b2a7467c152d16e4f19a9515aeb61fc9e3d | |
| ToppCell | 367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-05 | 191 | 86 | 5 | d31975fc33779b0b3ff1a50d7c64fec8d08be4d4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-05 | 191 | 86 | 5 | 24dc77ee8de01b42559f92721655f4281b114e17 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.62e-05 | 193 | 86 | 5 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.71e-05 | 194 | 86 | 5 | 5da8873cddff582e5693b32fd3aaebc102f65fc0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-05 | 194 | 86 | 5 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 198 | 86 | 5 | 5b9a7b9f53a3d9cf8d6e6a7c1c94514b22cf9fa8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.29e-05 | 200 | 86 | 5 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.07e-04 | 127 | 86 | 4 | fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 133 | 86 | 4 | 81189e8516a431d5890a0909f9fc7c82ec3442bc | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.32e-04 | 134 | 86 | 4 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-04 | 139 | 86 | 4 | f1d1a51a79afdddc82e73cd29b3240e3e973db28 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 147 | 86 | 4 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 147 | 86 | 4 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.94e-04 | 148 | 86 | 4 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.94e-04 | 148 | 86 | 4 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.94e-04 | 148 | 86 | 4 | f90ee6fbd71b5e0512af34867202f38409f4de38 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-04 | 149 | 86 | 4 | 5a5e9660f7d9b527f50a92d94d4c0c8aedb82c0b | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.09e-04 | 151 | 86 | 4 | 71841d2001200d1595c85c2b007ee20791a72927 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.09e-04 | 151 | 86 | 4 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.09e-04 | 151 | 86 | 4 | 60aced0c1cc6b509b73308d03d58a3c44d712ef4 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-04 | 155 | 86 | 4 | c648512305166d2a2f0e284c127bc802af908071 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.31e-04 | 155 | 86 | 4 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 156 | 86 | 4 | 39aa3adbee9f04cdc0055487d393edfa515e062b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 156 | 86 | 4 | a09e3aefe78d63ad5428ad48c6f83e547eb819f6 | |
| ToppCell | Control-Endothelial-Epi-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-04 | 157 | 86 | 4 | 4d02c50d5d1b892ea241e98724386d8a5a156a46 | |
| ToppCell | Control-Endothelial-Epi-like-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-04 | 157 | 86 | 4 | 2c369660c752c0fb3bd798a561d3359e2f9aa983 | |
| ToppCell | PND07-28-samps-Lymphocyte-T_cells|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.43e-04 | 157 | 86 | 4 | f3b4cde52423246ae6fc4924cd1ee502cf6c009c | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 158 | 86 | 4 | e1a8dba5a88bc3ce112829c5ecb112cbbee5b078 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 158 | 86 | 4 | b1b1e50ddd231dcd10cc8e6bb68b2a5e0bb1450a | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 158 | 86 | 4 | 72e4f8ae137a7dddee0dc6236532e0711065e6af | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-04 | 159 | 86 | 4 | 4b840da854390f8285c219314cff4434d7ffcacc | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-04 | 159 | 86 | 4 | d9e535cf9a0a2302268f2897b010dcecc6426e41 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-04 | 159 | 86 | 4 | 29999c87f5823f734e5cbf8ea8b729ec017db9b3 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 160 | 86 | 4 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 160 | 86 | 4 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.73e-04 | 162 | 86 | 4 | 10f7de4fb40ea9aee89bde3a280a82f6ccba2aeb | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.80e-04 | 163 | 86 | 4 | ec8336b68c8369e27d507c04c827be07bb48a7f6 | |
| ToppCell | COVID-mono3|COVID / Condition, Cell_class and T cell subcluster | 2.80e-04 | 163 | 86 | 4 | 6ab4cbcd411b40920b81162c0f4b03ea67408f52 | |
| ToppCell | COVID-mono3-|COVID / Condition, Cell_class and T cell subcluster | 2.80e-04 | 163 | 86 | 4 | 26661c7a3a0a449ed32d4b3b28fc2fc0b237025d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-04 | 66 | 86 | 3 | 57fd31a25addc48793d7975eadccf4c5a41a8b03 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-04 | 164 | 86 | 4 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | Frontal_cortex|World / BrainAtlas - Mouse McCarroll V32 | 2.86e-04 | 164 | 86 | 4 | e09291711abf8680e78170328313719092b0142f | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-04 | 164 | 86 | 4 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-04 | 164 | 86 | 4 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-04 | 164 | 86 | 4 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 164 | 86 | 4 | d0b6c29e61d15f4dbe4c1f6e5ed3e10f41f820ab | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 164 | 86 | 4 | 718cc64b7ef7d03d095be4b2b54c449154da568c | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.93e-04 | 165 | 86 | 4 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-04 | 166 | 86 | 4 | afba41e15478053f11815acf568d29187de75492 | |
| ToppCell | facs-Heart-RV-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 167 | 86 | 4 | f72c0ec1bb682c20bfaab726f9ee17a5a00cf0b1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.07e-04 | 167 | 86 | 4 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 3.14e-04 | 168 | 86 | 4 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 168 | 86 | 4 | f45dbcd7753117a3e41e1412bce2100d52fa7fd0 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-04 | 168 | 86 | 4 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 3.14e-04 | 168 | 86 | 4 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-04 | 168 | 86 | 4 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-04 | 168 | 86 | 4 | 17d46f993dc4ae22b8087808582aba77f5c61892 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-04 | 169 | 86 | 4 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-04 | 169 | 86 | 4 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 169 | 86 | 4 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 169 | 86 | 4 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 170 | 86 | 4 | 667443062882642211ad116043775ef8eda38859 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 3.28e-04 | 170 | 86 | 4 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 171 | 86 | 4 | 35acc5c3e36bc605603c0d45375f2cf3c3e9d4cd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-04 | 172 | 86 | 4 | 458fe1ae92620882dbc95c989a6da9b2ca216b5b | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 172 | 86 | 4 | 7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Mast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.43e-04 | 172 | 86 | 4 | a7146c255031207e64682ef767884b11c96e0d59 | |
| Drug | LY215840 | 1.80e-06 | 7 | 86 | 3 | CID000132049 | |
| Drug | AC1Q6PCP | 2.59e-06 | 230 | 86 | 8 | CID000005267 | |
| Drug | desipramine | 7.25e-06 | 188 | 86 | 7 | CID000002995 | |
| Drug | probenecid | 7.26e-06 | 123 | 86 | 6 | CID000004911 | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 9.52e-06 | 196 | 86 | 7 | 3225_UP | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; HL60; HT_HG-U133A | 1.02e-05 | 198 | 86 | 7 | 2358_UP | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; HL60; HT_HG-U133A | 1.02e-05 | 198 | 86 | 7 | 1265_UP | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; HL60; HG-U133A | 1.09e-05 | 200 | 86 | 7 | 1720_DN | |
| Drug | Midecamycin [35457-80-8]; Up 200; 5uM; PC3; HG-U133A | 1.09e-05 | 200 | 86 | 7 | 1943_UP | |
| Drug | verapamil | ABCC1 KCNT2 SLC22A4 SLC22A5 CACNA1H CACNA1G TAP1 CRH ADCY7 ABCB4 | 1.60e-05 | 490 | 86 | 10 | CID000002520 |
| Drug | Tetraethylammonium | 2.81e-05 | 16 | 86 | 3 | ctd:D019789 | |
| Drug | Technetium Tc 99m Sestamibi | 4.22e-05 | 3 | 86 | 2 | ctd:D017256 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 4.22e-05 | 3 | 86 | 2 | CID010679219 | |
| Drug | AC1L1E65 | 4.47e-05 | 52 | 86 | 4 | CID000002656 | |
| Drug | Verapamil | 4.91e-05 | 105 | 86 | 5 | ctd:D014700 | |
| Drug | cimetidine | 6.06e-05 | 179 | 86 | 6 | CID000002756 | |
| Drug | phorbol acetate myristate | COL2A1 ABCC1 ENPP7 IL17A CD6 DST SPN DGKA CACNA1H CACNA1G TNFRSF1A ITGAD SLC1A2 CRH ADCY7 ABCB4 | 6.14e-05 | 1399 | 86 | 16 | CID000004792 |
| Drug | 6-methylpurine-2'-deoxyriboside | 8.40e-05 | 61 | 86 | 4 | CID000097184 | |
| Drug | Dithioerythritol | 8.42e-05 | 4 | 86 | 2 | ctd:D004226 | |
| Drug | 15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A | 8.43e-05 | 190 | 86 | 6 | 1172_DN | |
| Drug | Flavonoids | COL2A1 GIPR ABCC1 DDR1 UBR5 SFTPB CGREF1 SLC22A5 CPA3 NMUR2 ST8SIA3 TAP1 CRH NRP1 | 8.59e-05 | 1136 | 86 | 14 | ctd:D005419 |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.00e-04 | 196 | 86 | 6 | 1686_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.00e-04 | 196 | 86 | 6 | 6708_DN | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A | 1.00e-04 | 196 | 86 | 6 | 5109_UP | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.00e-04 | 196 | 86 | 6 | 5060_DN | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; HL60; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 2141_DN | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 3924_UP | |
| Drug | Piperine [94-62-2]; Up 200; 14uM; HL60; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 1327_UP | |
| Drug | Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 86 | 6 | 3313_DN | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 86 | 6 | 3750_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 86 | 6 | 6106_UP | |
| Drug | Isocorydine (+) [475-67-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 86 | 6 | 6843_DN | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.09e-04 | 199 | 86 | 6 | 2866_UP | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.09e-04 | 199 | 86 | 6 | 3133_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 1.09e-04 | 199 | 86 | 6 | 4748_UP | |
| Drug | Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.12e-04 | 200 | 86 | 6 | 3438_DN | |
| Drug | Ethosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A | 1.12e-04 | 200 | 86 | 6 | 7308_DN | |
| Drug | hydroxamates | 1.13e-04 | 25 | 86 | 3 | CID000033630 | |
| Drug | sodium glycocholate | 1.36e-04 | 69 | 86 | 4 | CID000000755 | |
| Drug | AC1NV8Y2 | 1.40e-04 | 5 | 86 | 2 | CID005473939 | |
| Drug | Flunarizine | 1.40e-04 | 5 | 86 | 2 | DB04841 | |
| Disease | hypothyroidism (implicated_via_orthology) | 5.59e-06 | 13 | 81 | 3 | DOID:1459 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.15e-05 | 139 | 81 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Alcoholic Intoxication, Chronic | 9.74e-05 | 268 | 81 | 6 | C0001973 | |
| Disease | Coxsackievirus Infections | 1.11e-04 | 6 | 81 | 2 | C0010246 | |
| Disease | Arthritis | 1.11e-04 | 6 | 81 | 2 | C0003864 | |
| Disease | Myocarditis | 1.11e-04 | 6 | 81 | 2 | C0027059 | |
| Disease | Carditis | 1.11e-04 | 6 | 81 | 2 | C0869523 | |
| Disease | acetylcarnitine measurement | 2.06e-04 | 8 | 81 | 2 | EFO_0021038 | |
| Disease | butyrylcarnitine measurement | 2.06e-04 | 8 | 81 | 2 | EFO_0020010 | |
| Disease | Multiple Sclerosis | 2.60e-04 | 45 | 81 | 3 | C0026769 | |
| Disease | Multiple Sclerosis, Acute Fulminating | 2.60e-04 | 45 | 81 | 3 | C0751324 | |
| Disease | nervonoylcarnitine (C24:1) measurement | 2.65e-04 | 9 | 81 | 2 | EFO_0800549 | |
| Disease | polycystic ovary syndrome, type 2 diabetes mellitus | 3.30e-04 | 10 | 81 | 2 | EFO_0000660, MONDO_0005148 | |
| Disease | lignoceroylcarnitine (C24) measurement | 4.03e-04 | 11 | 81 | 2 | EFO_0800541 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 4.03e-04 | 11 | 81 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | uveitis (implicated_via_orthology) | 4.03e-04 | 11 | 81 | 2 | DOID:13141 (implicated_via_orthology) | |
| Disease | Inflammation | 4.21e-04 | 127 | 81 | 4 | C0021368 | |
| Disease | Cooley's anemia | 4.83e-04 | 12 | 81 | 2 | C0002875 | |
| Disease | Thalassemia Intermedia | 4.83e-04 | 12 | 81 | 2 | C0271979 | |
| Disease | tryptophan betaine measurement | 4.83e-04 | 12 | 81 | 2 | EFO_0021017 | |
| Disease | hexanoylcarnitine measurement | 4.83e-04 | 12 | 81 | 2 | EFO_0021040 | |
| Disease | Thalassemia Minor | 4.83e-04 | 12 | 81 | 2 | C0085578 | |
| Disease | beta Thalassemia | 4.83e-04 | 12 | 81 | 2 | C0005283 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 5.51e-04 | 58 | 81 | 3 | DOID:7148 (is_implicated_in) | |
| Disease | uveitis (is_marker_for) | 5.69e-04 | 13 | 81 | 2 | DOID:13141 (is_marker_for) | |
| Disease | homostachydrine measurement | 5.69e-04 | 13 | 81 | 2 | EFO_0021164 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 5.69e-04 | 13 | 81 | 2 | EFO_0800547 | |
| Disease | cerotoylcarnitine (C26) measurement | 5.69e-04 | 13 | 81 | 2 | EFO_0800542 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 6.63e-04 | 14 | 81 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | Mental Depression | 6.83e-04 | 254 | 81 | 5 | C0011570 | |
| Disease | Schizophrenia | 7.03e-04 | 883 | 81 | 9 | C0036341 | |
| Disease | Hemoglobin F Disease | 7.64e-04 | 15 | 81 | 2 | C0019025 | |
| Disease | Intrahepatic cholestasis of pregnancy | 8.71e-04 | 16 | 81 | 2 | EFO_0009048 | |
| Disease | Liver Dysfunction | 1.04e-03 | 72 | 81 | 3 | C0086565 | |
| Disease | Anorexia | 1.11e-03 | 18 | 81 | 2 | C0003123 | |
| Disease | respiratory syncytial virus infectious disease (is_marker_for) | 1.11e-03 | 18 | 81 | 2 | DOID:1273 (is_marker_for) | |
| Disease | behavioural disinhibition measurement | 1.17e-03 | 75 | 81 | 3 | EFO_0006946 | |
| Disease | Mood Disorders | 1.20e-03 | 168 | 81 | 4 | C0525045 | |
| Disease | carnitine measurement | 1.21e-03 | 76 | 81 | 3 | EFO_0010469 | |
| Disease | Depressive disorder | 1.22e-03 | 289 | 81 | 5 | C0011581 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 1.23e-03 | 19 | 81 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | oleoylcarnitine measurement | 1.23e-03 | 19 | 81 | 2 | EFO_0021043 | |
| Disease | Weight decreased | 1.81e-03 | 23 | 81 | 2 | C1262477 | |
| Disease | stearoylcarnitine measurement | 1.98e-03 | 24 | 81 | 2 | EFO_0021045 | |
| Disease | obesity (is_implicated_in) | 2.03e-03 | 91 | 81 | 3 | DOID:9970 (is_implicated_in) | |
| Disease | adult respiratory distress syndrome (is_marker_for) | 2.32e-03 | 26 | 81 | 2 | DOID:11394 (is_marker_for) | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 2.44e-03 | 97 | 81 | 3 | DOID:3083 (is_marker_for) | |
| Disease | Fever | 2.50e-03 | 27 | 81 | 2 | C0015967 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 2.59e-03 | 99 | 81 | 3 | DOID:11446 (biomarker_via_orthology) | |
| Disease | corpus callosum volume measurement | 2.66e-03 | 100 | 81 | 3 | EFO_0010299 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 2.69e-03 | 28 | 81 | 2 | DOID:4194 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVPAVVGSALLLLML | 1151 | Q6UXC1 | |
| LLELPLLLSMLGTVL | 171 | Q6UXZ3 | |
| MLQGLLPVSLLLSVA | 1 | Q9UKQ2 | |
| MGPEALSSLLLLLLV | 1 | Q08345 | |
| LVGLLVMPLSLLAIL | 101 | P28335 | |
| SIPLTEGLDLISMLT | 3446 | Q96DT5 | |
| PPDMILTLLEGITAI | 1716 | Q5JWR5 | |
| MTTSPILQLLLRLSL | 1 | P48546 | |
| LSVMSSPSILLVVLL | 1181 | O60423 | |
| IGSLLTVAIINLPLM | 676 | P51828 | |
| MTVLILLLLPTGQAA | 6 | Q99674 | |
| PLIPMLVIIETISLL | 136 | P00846 | |
| QSLLLTMLVGPLIAI | 486 | Q2TB18 | |
| MIRLGAPQTLVLLTL | 1 | P02458 | |
| ITLRMLGSLASIIPE | 121 | Q9NVH2 | |
| TLSNMGILPALEVIL | 356 | Q6IN85 | |
| SRELMLLIPSIVLGI | 396 | P30203 | |
| PGLTGVVLLLILAIM | 1191 | Q9NRD9 | |
| MGILSVDLLITLQIL | 1 | Q92813 | |
| GTTLVPLTTLKNILM | 996 | O60309 | |
| ALPKSGLLMSLLVVI | 281 | Q8N7X4 | |
| GTTLVPLTTLKNILM | 996 | A6NM11 | |
| GTTLVPLTTLKNILM | 996 | A6NMS7 | |
| GMSVVLVLLPTLLLV | 11 | Q86VH4 | |
| LVLLPTLLLVMLTGA | 16 | Q86VH4 | |
| SLAVSDLLVLLLGMP | 86 | Q9GZQ4 | |
| MATLLLLLGVLVVSP | 1 | P16150 | |
| LLETQLMISGLISPE | 1586 | Q03001 | |
| TSGVLILMLPLSLIA | 201 | Q8NG97 | |
| VSDIGLVTALMPTLL | 76 | Q8NGJ8 | |
| LVTALMPTLLGIALA | 81 | Q8NGJ8 | |
| KISIPMLLTLSITGI | 596 | Q8TET4 | |
| TLDPILITIIAMSSL | 861 | O60462 | |
| TTVPLLVLLGLEMTL | 186 | P23743 | |
| TLPLILGLILGLVIM | 236 | Q9UJQ1 | |
| LGLILGLVIMVTLAI | 241 | Q9UJQ1 | |
| MVPLLTSTKDLVISL | 1501 | P50748 | |
| MISITRLLLGLDTTP | 906 | Q6UVM3 | |
| MRLPLLVSAGVLLVA | 1 | P06850 | |
| IFMVLILPSLGLTSL | 511 | O94886 | |
| MTPGKTSLVSLLLLL | 1 | Q16552 | |
| VLGLTLLISMILAVL | 176 | O95297 | |
| LMRLLQQLTGITPIL | 281 | Q9UGQ3 | |
| LTLVIMAISPILGLS | 216 | P21439 | |
| IPIIMGSSVGALLLL | 1101 | Q13349 | |
| LVTMAPIVLILLGLL | 486 | Q8NA29 | |
| LKTLDPILITIIAMS | 851 | O14786 | |
| PILITIIAMSALGVL | 856 | O14786 | |
| LEILLTSVIIPKMLS | 71 | Q8NH40 | |
| LLSVPVLSSLLLQMV | 996 | Q9NQ11 | |
| LGLQMLSLTVPLSEE | 381 | P83105 | |
| MRLILPVGLIATTLA | 1 | P15088 | |
| TILILMPTISLIENK | 361 | P00156 | |
| VTLLLDTLPMLGNVL | 201 | O43497 | |
| MLILPLIISSLITGL | 91 | P43004 | |
| SIPSAGLVTMLLILT | 441 | P43004 | |
| GLVTMLLILTAVGLP | 446 | P43004 | |
| MKTLPVLVLSLTLLT | 1 | Q0P5P2 | |
| ALILSMAVPTIIGLS | 526 | Q7Z388 | |
| PVLMLLLLLGLIDIS | 11 | P02746 | |
| MTPLLTLILVVLMGL | 1 | P0DP58 | |
| LLLTVPAAVILMLNT | 846 | Q8IWT3 | |
| LLSLPVLAAGITMLL | 196 | P00395 | |
| PLLVMGLLGTVILLS | 441 | Q6UWV6 | |
| TLLLDTLPMLGNVLL | 221 | O95180 | |
| MEPVTALGILSLILN | 181 | Q9BRL7 | |
| IVMGSLTVLIGILTL | 491 | Q9H015 | |
| PYILMGSLTILTAIL | 491 | O76082 | |
| IGLLTTMAILLHEIP | 246 | Q96H72 | |
| LISTGLTTLILGIVM | 126 | Q08AI6 | |
| EMGLLLLSVVVTSRP | 136 | Q8TEX9 | |
| LVMPILQILSSTALE | 351 | Q5VW36 | |
| FLVSPTLLGITMLLA | 106 | P33527 | |
| LIIPTIMATITLLNL | 276 | P03891 | |
| LLMLSVPFLVTSTLL | 106 | P30872 | |
| ISPLMLLSLLIASVV | 576 | Q9H2J7 | |
| GVMSLLRTLLLDVVP | 41 | O75602 | |
| LMELGISPIVTSGLI | 76 | Q9H9S3 | |
| ILLDTLLGRMLPQLV | 256 | P07988 | |
| MKPLSLLIEILIILG | 1 | Q5TEA6 | |
| TQLSLVLMSLLLVLP | 6 | A4D0T7 | |
| SVLGLVMLSVALLIL | 11 | O43173 | |
| LVLVVLSSLGEMAIP | 191 | Q03518 | |
| SLTMVTLITLPLLFL | 326 | Q03518 | |
| SPVLGMITGTLILIL | 266 | Q8IVW8 | |
| MITGTLILILVPATK | 271 | Q8IVW8 | |
| GVMRSISLLEPSLEL | 536 | Q8TE77 | |
| MGLLLLVLILTPSLA | 1 | P60508 | |
| MSSLIEVVIGLLGLP | 221 | Q9UGH3 | |
| IAMVLLSLLTPILGI | 556 | Q8IXW5 | |
| LMELGISPIVTSGLI | 76 | P61619 | |
| LVLVLGTILLPAVTM | 46 | Q6PEY1 | |
| GLETMLPLLLTAVSE | 1706 | P27708 | |
| LLALEGELTPILVQM | 581 | O43314 | |
| ALEMPGISLTLLLVD | 306 | Q3LXA3 | |
| MGLSTVPDLLLPLVL | 1 | P19438 | |
| ITGMLLELSPAQLLL | 2416 | O95071 | |
| LRSLIPAVLTVSMLG | 531 | Q6NSJ0 |